News Breaks |
|
|
| October 4, 2012 |
| 07:07 EDT |  | SRPT | Sarepta price target raised to $50 from $18 at JMP Securities
JMP Securities raised its price target for Sarepta after the company announced Eteprilsen date for the treatment of Duchene's Muscular Dystrophy. The firm views the data as additional evidence of a durable drug effect and keeps an Outperform rating on the name. |
|
|
News For SRPT From The Last 14 Days Check below for free stories on SRPT the last two weeks. |
|
|
| May 21, 2013 |
| 07:34 EDT |  | SRPT | UBS to host a conference
 Subscribe for More Information |
|
| May 16, 2013 |
| 07:29 EDT | | SRPT | Leerink to host a bus tour
Boston Biopharma Bus Tour travels throughout Boston on May 16-17. |
|
|
|
|
|
